CVS Health — Feb 10, 2026 release

Year Ending December 31, 2026 Low High In millions, except per share amounts Total Company Per Common Share Total Company Per Common Share Net income attributable to CVS Health (GAAP measure) $ 7,638  $ 5.94  $ 7,892  $ 6.14  Non-GAAP adjustments: Amortization of intangible assets 1,730  1.35  1,730  1.35  Acquisition-related integration costs 80  0.06  80  0.06  Tax impact of non-GAAP adjustments (450) (0.35) (450) (0.35) Adjusted income attributable to CVS Health (2) $ 8,998  $ 7.00  $ 9,252  $ 7.20  Weighted average diluted shares outstanding 1,285  1,285  23 Endnotes (1) The Company defines adjusted operating income as operating income (GAAP measure) excluding the impact of amortization of intangible assets, net realized capital gains or losses and other items, if any, that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business performance, such as acquisition-related integration costs, goodwill impairment charges, Health Care Delivery clinic closure charges, opioid litigation charges, office real estate optimization charges, certain legacy litigation charges, losses on Accountable Care assets and restructuring charges. The CODM uses adjusted operating income as its principal measure of segment performance as it enhances the CODM’s ability to compare past financial performance with current performance and analyze underlying business performance and trends. The consolidated measure is not determined in accordance with GAAP and should not be considered a substitute for, or superior to, the most directly comparable GAAP measure, consolidated operating income. See “Non-GAAP Financial Information” earlier in this press release for additional information regarding the items e